Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis
article
OA: closed
CC0
⤵ 117 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study analyzed the distribution of estrogen and progesterone receptor isoforms in uteri with and without adenomyosis across the menstrual cycle.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (60)
- Adenomyosis: via openalex
- Adenomyosis uteri: an update via openalex
- Clinical usefulness of determination of estradiol level in the menstrual blood for patients with endometriosis. via openalex
- Dating the Endometrial Biopsy via openalex
- Effect of the menstrual cycle and oral contraceptives on aromatase and cyclooxygenase-2 expression in adenomyosis via openalex
- Endometrial-Myometrial Interface: Relationship to Adenomyosis and Changes in Pregnancy via openalex
- Endometriosis: a dysfunction and disease of the archimetra via openalex
- Estrogen receptor-alpha (ER-alpha) and defects in uterine receptivity in women via openalex
- Insertion of Mirena after Endometrial Resection in Patients with Adenomyosis via openalex
- Intact progesterone receptors are essential to counteract the proliferative effect of estradiol in a genetically engineered mouse model of endometriosis via openalex
- Neonatal administration of tamoxifen causes disruption of myometrial development but not adenomyosis in the C57/BL6J mouse via openalex
- Ovarian steroid receptor expression in endometriosis and in two potential parent epithelia: endometrium and peritoneal mesothelium via openalex
- Phenotypic Characterisation of the Inner and Outer Myometrium in Normal and Adenomyotic Uteri via openalex
- Promoter Hypermethylation of Progesterone Receptor Isoform B (PR-B) in Adenomyosis and Its Rectification by a Histone Deacetylase Inhibitor and a Demethylation Agent via openalex
- Surgical and medical treatment of adenomyosis via openalex
- Treatment of Endometriosis with Estrogen-Progestin Combination and Progestogens Alone via openalex
- W2016344930 via openalex
- W2017110402 via openalex
- W2028950695 via openalex
- W2033232788 via openalex
- W2033945601 via openalex
- W2034864360 via openalex
- W2065088050 via openalex
- W2065955514 via openalex
- W2079078286 via openalex
- W2110922412 via openalex
- W2121201031 via openalex
- W2121475182 via openalex
- W2122148434 via openalex
- W2124561299 via openalex
- W2127954353 via openalex
- W2137852967 via openalex
- W2141269411 via openalex
- W2150003940 via openalex
- W2151274670 via openalex
- W2155274896 via openalex
- W2160027012 via openalex
- W2160756193 via openalex
- W2166188229 via openalex
- W2166673284 via openalex
- W2394566517 via openalex
- W2396340237 via openalex
- W6609642172 via openalex
- W6641683417 via openalex
- W6684733989 via openalex
- W1579407907 via openalex
- W1749510241 via openalex
- W1907234242 via openalex
- W1927161069 via openalex
- W1965397941 via openalex
- W1966488185 via openalex
- W1968277161 via openalex
- W1970917001 via openalex
- W1971324961 via openalex
- W1988649251 via openalex
- W1994523467 via openalex
- W1999415440 via openalex
- W2004270170 via openalex
- W2007283211 via openalex
- W2012994584 via openalex
Cited by (50)
- Adenomyosis and fertility: from pathophysiology to optimizing reproductive outcomes 2026
- Shared Biology Underlying Benign Endometrial Diseases and Endometrial Cancer: Current Knowledge and Future Prospectives 2026
- Hormone receptor profile of ectopic and eutopic endometrium in adenomyosis: a systematic review 2025
- Molecular Basis of Impaired Decidualization in the Eutopic Endometrium of Endometriosis Patients 2025
- Characteristics of factors contributing to disorders of reproductive function in patients with adenomyosis 2025
- Adenomyosis’ association with low progesterone yet increased interleukin-6, vascular endothelial growth factor and cyclooxygenase-2 2025
- Mutation profile and chromosomal abnormality in adenomyosis 2025
- Progressively diminished estrogen signaling concordant with increased fibrosis in ectopic endometrium 2025
- Retrospective Study on the Incidence of Benign, Premalignant, and Malignant Gynecologic Disorders in Patients with Adenomyosis: Analysis of 5648 Specimens 2024
- Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
- Overview of crosstalk between stromal and epithelial cells in the pathogenesis of adenomyosis and shared features with deep endometriotic nodules 2024
- Additional file 2 of Improvement of early miscarriage rates in women with adenomyosis via oxytocin receptor antagonist during frozen embryo transfer-a propensity score-matched study 2024
- Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
- Additional file 2 of Improvement of early miscarriage rates in women with adenomyosis via oxytocin receptor antagonist during frozen embryo transfer-a propensity score-matched study 2024
- Biological characteristics related to treatment effects of the levonorgestrel-releasing intrauterine system on adenomyosis-associated dysmenorrhoea 2024
- Additional file 1 of Improvement of early miscarriage rates in women with adenomyosis via oxytocin receptor antagonist during frozen embryo transfer-a propensity score-matched study 2024
- Impaired fertility in adenomyosis: a murine model reveals endometrial receptivity and progesterone resistance imbalances 2024
- Additional file 1 of Improvement of early miscarriage rates in women with adenomyosis via oxytocin receptor antagonist during frozen embryo transfer-a propensity score-matched study 2024
- The Role of Platelets in the Pathogenesis and Pathophysiology of Adenomyosis 2023
- The effect of hormone-modulating therapy during pregravid preparation on the course of pregnancy and childbirth in patients with a history of endometriosis 2023
- Exosomes: potential diagnostic markers and drug carriers for adenomyosis 2023
- Establishment of an immortalized cell line derived from human adenomyosis ectopic lesions 2023
- Characterising the immune cell phenotype of ectopic adenomyosis lesions compared with eutopic endometrium: A systematic review 2023
- The “freeze-all” strategy seems to improve the chances of birth in adenomyosis-affected women 2023
- Quand intervenir en cas d'endométriose avant AMP ? 2023
- Endometrial receptivity in adenomyosis and the role of signaling pathways in the pathogenesis of the disease (literature review) 2022
- There is no significant correlation of adenomyosis with benign, premalignant and malignant gynecological pathologies. Retrospective study on 647 specimens 2022
- Contribution des modèles mathématiques 2022
- Mechanisms and Pathogenesis of Adenomyosis 2022
- Molecular Targets for Nonhormonal Treatment Based on a Multistep Process of Adenomyosis Development 2022
- Neonatal feeding of an estrogen receptor β agonist induces external adenomyosis-like lesions in ICR mouse 2022
- Characteristics of endometrial hormonal homeostasis and receptor apparatus in women with adenomyosus who had papillary thyroid carcinoma 2022
- Expressão das proteínas reguladoras da biogênese dos miRNAs em lesões de adenomiose 2022
- Immunohistochemical expression of Drosha is reduced in eutopic and ectopic endometrium of women with adenomyosis 2022
- Neonatal feeding of an estrogen receptor β agonist induces external adenomyosis-like lesions in ICR mouse 2022
- Mechanism Study of Cinnamomi Ramulus and Paris polyphylla Sm. Drug Pair in the Treatment of Adenomyosis by Network Pharmacology and Experimental Validation 2022
- Pathogenesis of Human Adenomyosis: Current Understanding and Its Association with Infertility 2022
- Functional Implications of Estrogen and Progesterone Receptors Expression in Adenomyosis, Potential Targets for Endocrinological Therapy 2022
- Insights on Adenomyosis Development 2022
- Progesterone Actions and Resistance in Gynecological Disorders 2022
- Uterine bleeding: how understanding endometrial physiology underpins menstrual health 2022
- Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New ’Hit Hard First and then Maintain’ Regimen of Administration 2021
- Scribble downregulation in adenomyosis compromises endometrial stromal decidualization by decreasing FOXO1 expression 2021
- Physiopathologie de l’adénomyose : une énigme non résolue 2021
- Adenomyosis and in vitro fertilization impacts - A literature review 2021
- Adenomyosis pathogenesis: insights from next-generation sequencing 2021
- Talin1 Induces Epithelial-Mesenchymal Transition to Facilitate Endometrial Cell Migration and Invasion in Adenomyosis Under the Regulation of microRNA-145-5p 2021
- Clinical outcomes after single-versus double-embryo transfers in women with adenomyosis: a retrospective study 2021
- The Role of Abnormal Uterine Junction Zone in the Occurrence and Development of Adenomyosis 2021
- Impaired decidualization of human endometrial stromal cells from women with adenomyosis† 2021
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:16:48.482574+00:00
License: CC0
· commercial use OK